Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > PR > Is This What PR's All About?

Tags

  • releases
  • strategic
  • biological
  • combination products
  • important outside

  • Links

  • Exclusive Wedding Jewellery
  • Growing Up Differently
  • An Industry Where Jobs Are NOT Exported
  • Digg It - Is This What PR's All About?

    Simply moving messages from one point to another using tactics like press releases, special events, brochures and broadcast plugs?

    Good gosh, I hope not!

    Not when many business, non-profit, government agency and association managers badly need to do something both positive and meaningful about the behaviors of those important outside audiences of theirs who
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    se behaviors MOST affect the departmental, divisional or subsidiary unit they manage.

    These are the same managers who need the kind of public relations effort that leads them directly to achieving their managerial objectives; in particular by persuading those key outside folks to the manager’s way of thinking by helping move audience members to take acti
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ns that help the manager’s department, group, division or subsidiary to succeed.

    As long-ago news commentator Gabriel Heater used to say, “Ah, there’s good news tonight!” Here, that good news is the fact that the right public relations planning really CAN alter individual perception and result in changed behaviors among key outside audiences. Achievabl
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    e, incidentally, only when you as a manager require more than news releases, special events and broadcast plugs. When that happens, you should receive the quality public relations results you deserve.

    Here’s the way public relations’ underlying premise puts it: people act on their own perception of the facts before them, which leads to predictable behavior
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    about which something can be done. When we create, change or reinforce that opinion by reaching, persuading and moving-to-desired-action the very people whose behaviors affect the organization the most, the public relations mission is usually accomplished.

    Sample some of the playback that can come about from this kind of public relations: community leade
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    s begin to seek you out; capital givers or specifying sources start to look your way; welcome bounces in show room visits occur; new prospects actually start to do business with you; politicians and legislators begin looking at you as a key member of the business, non-profit or association communities; new proposals for strategic alliances and joint ven
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    tures start showing up; customers begin to make repeat purchases; and membership applications start to rise.

    Look first to your public relations professionals, who are already in the perception and behavior business, to handle your data gathering activity, an essential component of your new opinion monitoring project. But be certain that the PR staff reall
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    accepts why it’s SO important to know how your most important outside audiences perceive your operations, products or services. Essentially, be sure they truly believe that perceptions almost always result in behaviors that can help or hurt your operation.

    Together with your PR specialists, analyze your plans for monitoring and gathering perceptions by q
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    uestioning members of your most important outside audiences. Suggest that the staff consider questions like these: how much do you know about our organization? Have you had prior contact with us and were you pleased with the exchange? Are you familiar with our services or products and employees? Have you experienced problems with our people or procedure
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ?

    Retaining a professional survey firm to do the opinion gathering work, can strain your budget and end up more expensive than using your own staff people. But whether it’s your people or a survey firm asking the questions, the objective remains the same: identify untruths, false assumptions, unfounded rumors, inaccuracies, misconceptions and any other ne
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ative perception that might translate into hurtful behaviors.

    This is where we establish a clearcut and realistic PR goal calling for action on the most serious problem areas you uncovered during your key audience perception monitoring. You may decide to straighten out that dangerous misconception, bring to an end that potentially painful rumor, or corre
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ct that gross inaccuracy.

    Since goal and strategy go together like Oreo cookies and milk, you must connect your goal to an action- oriented strategy that shows how to get to where you’re going. Actually, you have just three strategic options available to you when it comes to doing something about perception and opinion. Change existing perception, creat
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    perception where there may be none, or reinforce it. Needless to say, the wrong strategy pick will taste like whipped cream on your pot roast. So be sure your new strategy fits well with your new public relations goal. You certainly don’t want to select “change” when the facts dictate a strategy of reinforcement.

    Now you must task your team’s best write
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    r to prepare a persuasive message that will help move your key audience to your way of thinking. It has to be a carefully -written message targeted directly at your key external audience. S/he must produce some really corrective language that is not merely compelling, persuasive and believable, but clear and factual if they are to shift perception/opinio
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    towards your point of view and lead to the behaviors you have in mind.

    Luckily for you, the right communications tactics will carry your message to the attention of your target audience? There are many tactics available from speeches, facility tours, emails and brochures to consumer briefings, media interviews, newsletters, personal meetings and many ot
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ers. But be certain that the tactics you pick are known to reach folks just like your audience members.

    Since the means by which you communicate your message is always a concern because its credibility is fragile and always suspect, you may wish initially to unveil your corrective message before smaller meetings through presentations rather than using
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    higher-profile news releases.

    Measuring how far you’ve come since the program’s inception, you’ll want to compare where you are now against the starting point to show the progress you’ve made. First, you’ll be demonstrating, in the form of periodic progress reports, how the monies spent on public relations can pay off. However, it’s also an alert to start
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    a second perception monitoring session with members of your external audience. Here, you’ll use many of the same questions used in the benchmark interviews. But now, you will be on strict alert for signs that the bad news perception is being altered in your direction.

    Without doubt, you will face periodic slowdowns in the program. Generally, adding more c
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ommunications tactics, and/or increasing their frequencies, usually solves that problem.

    As asked up front: Is PR all about moving messages from one point to another using familiar tactics? I said Good Gosh, I hope not! And I still say, Good Gosh, I hope not!

    Much preferred are managers who decide they no longer wish to be denied the best public relatio
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    s has to offer, preferring instead to pursue the quality public relations results they believe they deserve.

    Please feel free to publish this article and resource box in your ezine, newsletter, offline publication or website. A copy would be appreciated at bobkelly@TNI.net. Word count is 1220 including guidelines and resource box. Robert A. Kelly © 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/33759/diggit-Is-This-What-PRs-All-About.html">Is This What PR's All About?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/33759/diggit-Is-This-What-PRs-All-About.html]Is This What PR's All About?[/url]

    Related Articles:

    Why You Shouldnt Waste Your Time Selling Low Ticket Items

    Give Your Business An Oscar Moment

    How Companies Can Effectively Manage Storm Water Pollution

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com